Lv6
2330 积分 2024-03-11 加入
Exploiting selective BCL-2 family inhibitors to dissect cell survival dependencies and define improved strategies for cancer therapy
8天前
已完结
Inhibition of FOXM1 Synergizes with BH3 Mimetics Venetoclax and Sonrotoclax in Killing Multiple Myeloma Cells through Repressing MYC Pathway
21天前
已完结
Discovery of a Covalent Inhibitor That Overcame Resistance to Venetoclax in AML Cells Overexpressing BFL-1
23天前
已完结
Sonrotoclax: First Approval
27天前
已完结
FLT3 inhibition by olverembatinib (HQP1351) downregulates MCL-1 and synergizes with BCL-2 inhibitor lisaftoclax (APG-2575) in preclinical models of FLT3-ITD mutant acute myeloid leukemia
30天前
已关闭
Ph-Positive Acute Lymphoblastic Leukemia — 25 Years of Progress
1个月前
已完结
Optimized Induction of Mitochondrial Apoptosis By Combination Therapies with Venetoclax for Chemotherapy-Free Treatment of BCR-ABL+ Acute Lymphoblastic Leukemia in Preclinical Models
1个月前
已关闭
Optimized Induction of Mitochondrial Apoptosis By Combination Therapies with Venetoclax for Chemotherapy-Free Treatment of BCR-ABL+ Acute Lymphoblastic Leukemia in Preclinical Models
1个月前
已完结
Dasatinib overcomes glucocorticoid resistance in B-cell acute lymphoblastic leukemia
1个月前
已完结
Advances in the treatment of Philadelphia chromosome negative acute lymphoblastic leukemia
1个月前
已完结
皖公网安备34019202002308
